EVALUATION OF PATIENT, VIRUS AND TREATMENT BASELINE FACTORS AFFECTING THE EFFECTIVENESS OF DIRECT ANTIVIRAL AGENTS AGAINST THE HEPATITIS C VIRUS
6ER-033
PHARMACY RESIDENTS’ TRAINING TO ON-CALL DUTIES IN HOSPITAL PHARMACIES: SURVEY OF FRENCH TRAINING PROGRAMMES AND OPTIMISATION OF A LOCAL TRAINING PROGRAMME
6ER-027
HOME MEDICINE STORAGE HABITS AMONG PATIENTS ATTENDING OUTPATIENT PHARMACY SERVICES
6ER-025
PHARMACIST CLINICIANS IN HOSPITALS – TRANSFORMING THE WORKFORCE WITH NEW MODELS OF PATIENT CARE
6ER-023
IMPACT OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE POLYMORPHISM G894T ON THE DEVELOPMENT OF TYPE-2 DIABETES
6ER-009
CAN TOLERABILITY AND SAFETY OF DAA-2 FOR HEPATITIS C BE ESTIMATED ONLY BY RANDOMISED CLINICAL TRIALS? A SYSTEMATIC REVIEW WITH META-ANALYSIS
6ER-006
USE OF PIPERACILLIN-TAZOBACTAM IN A UNIVERSITY HOSPITAL
6ER-001
ASSOCIATION BETWEEN FAECAL CALPROTECTIN VALUES AND INFLIXIMAB TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS
6ER-032
DESIGN AND IMPLEMENTATION OF A PHARMACY TECHNICIAN TRAINING PROGRAMME TO IMPROVE OUTPATIENT DRUG DISPENSING
6ER-029
SPANISH HOSPITAL PHARMACY TWITTERSPHERE: A QUANTITATIVE STUDY
6ER-017
ASSESSMENT OF DRUG PRESCRIPTION USING THE WORLD HEALTH ORGANISATION (WHO) INDICATORS AT A PUBLIC HOSPITAL
6ER-016
ANALYSIS OF PRESCRIBED TREATMENTS FOR PATIENTS WITH PULMONARY HYPERTENSION IN A PROVINCIAL HOSPITAL
6ER-011
DRUG UTILISATION STUDY OF BEVACIZUMAB IN A TEACHING REFERRAL PAEDIATRIC HOSPITAL
6ER-007
IMPACT OF OPTIMISING USE OF CARBAPENEM ANTIBIOTICS PROGRAMME
6ER-005
COMPREHENSIVE PROGRAMME FOR PREVENTION AND CONTROL OF INFECTIONS RELATED TO HEALTH CARE AND APPROPRIATE USE OF ANTIMICROBIALS: ONE MORE STEP
